Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CFB | P00751 | 1/20 | 0.39 |
| ▸ | OPRL1 | P41146 | 3/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.38 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.38 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.36 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.36 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.35 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.35 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.35 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.35 |
| ▸ | PRCP | P42785 | 1/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.35 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL246216 | 1.00 | CFB (0.39) | CFBOPRL1OPRM1SLC6A9HSD11B1 | |
| SCHEMBL29908655 | 1.00 | CFB (0.39) | CFBOPRL1OPRM1SLC6A9HSD11B1 | |
| SCHEMBL606913 | 1.00 | CFB (0.39) | CFBOPRL1OPRM1SLC6A9HSD11B1 | |
| SCHEMBL28282470 | 0.98 | CFB (0.38) | CFBOPRL1OPRM1SLC6A9HSD11B1 | |
| SCHEMBL9561702 | 0.98 | CFB (0.38) | CFBOPRL1OPRM1SLC6A9HSD11B1 | |
| Hydrochloric Acid SCHEMBL28274724 | 0.98 | CFB (0.38) | CFBOPRL1OPRM1SLC6A9HSD11B1 | |
| Hydrochloric Acid SCHEMBL8207460 | 0.98 | CFB (0.38) | CFBOPRL1OPRM1SLC6A9HSD11B1 | |
| Hydrochloric Acid SCHEMBL9257449 | 0.98 | CFB (0.38) | CFBOPRL1OPRM1SLC6A9HSD11B1 | |
| SCHEMBL27866641 | 0.98 | CFB (0.38) | CFBOPRL1OPRM1SLC6A9HSD11B1 | |
| SCHEMBL2190183 | 0.94 | CFB (0.36) | CFBOPRL1OPRM1SLC6A9HSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 351 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4633638-A1 | TREATMENT OF PSYCHOLOGICAL FACTORS AFFECTING OTHER MEDICAL CONDITIONS (PFAOMC) | Luminous Mind Inc. (US) | 2025-10-22 | — | — | EP | claimed |
| EP-4615506-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | Sahin, Fikret (TR) | 2025-09-17 | — | — | EP | claimed |
| CN-119930414-A | Asymmetric synthesis method of bicyclo [2.2.2] octane-2, 5-dione | 暨南大学 | 2025-05-06 | — | — | CN | claimed |
| WO-2024258363-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | SAHIN FIKRET (TR) | 2024-12-19 | — | — | WO | claimed |
| WO-2024130044-A1 | TREATMENT OF PSYCHOLOGICAL FACTORS AFFECTING OTHER MEDICAL CONDITIONS (PFAOMC) | LUMINOUS MIND INC. (US) | 2024-06-20 | — | — | WO | claimed |
| US-20220323380-A1 | DRUG COMBINATION FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES | ISANAS AG (CH) | 2022-10-13 | — | — | US | claimed |
| EP-3986391-A1 | DRUG COMBINATION FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES | Isanas AG (CH) | 2022-04-27 | — | — | EP | claimed |
| CN-113943317-A | Preparation method of MeCBS solid | 大连双硼医药化工有限公司 | 2022-01-18 | — | — | CN | claimed |
| CN-109678738-B | Method for synthesizing (2S,3S) -3-amino-bicyclo [2.2.2] octane-2-formate | 深圳市华先医药科技有限公司 | 2021-11-30 | — | — | CN | claimed |
| WO-2020254509-A1 | DRUG COMBINATION FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES | ISANAS AG (CH) | 2020-12-24 | — | — | WO | claimed |
| CN-106008166-A | Industrialized production method of chiral 2- chloro-1-(2,4-dichlorophenyl) ethanol | 上海福乐医药科技有限公司 | 2016-10-12 | — | — | CN | claimed |
| EP-2734514-B1 | USE OF A THIOPHENE COMPOUND AS A MATRIX IN THE SPECIFIC DETECTION, IDENTIFICATION AND/OR QUANTIFICATION OF ALKALOIDS BY MALDI-TOF MASS SPECTROMETRY | UNIV ANGERS (FR) | 2015-07-08 | — | — | EP | claimed |
| US-20140319331-A1 | NEW USE FOR A COMPOUND AS A MATRIX IN THE SPECIFIC DETECTION, IDENTIFICATION AND/OR QUANTIFICATION OF ALKALOIDS BY MALDI-TOF MASS SPECTROMETRY | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS (FR) | 2014-10-30 | — | — | US | claimed |
| US-20120041225-A1 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | VAIDYA NITEEN A (US) | 2012-02-16 | — | — | US | claimed |
| CN-102170874-A | Compositions and methods for treating psychiatric disorders | GOSFORTH CT HOLDINGS PTY LTD | 2011-08-31 | — | — | CN | claimed |
| CN-101798326-A | Chiral PCN pincerlike metal compound derived from diphenyl prolinol and synthesis method thereof | UNIV ZHENGZHOU | 2010-08-11 | — | — | CN | claimed |
| EP-1981831-A2 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | Vaidya, Niteen A. (US) | 2008-10-22 | — | — | EP | claimed |
| WO-2007092264-A2 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | VAIDYA NITEEN A (US) | 2007-08-16 | — | — | WO | claimed |
| US-20070185346-A1 | Kit for automated resolving agent selection and method thereof | VAIDYA NITEEN A | 2007-08-09 | — | — | US | claimed |
| EP-0453288-A1 | Enantiospecific synthesis of S(+)-5,6-dihydro-4-(R-amino)-4H thieno (2,3-B)thiopyran-2-sulfonamide-7,7-dioxide | MERCK & CO. INC. (US) | 1991-10-23 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120041225-A1 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | ACKR3, KIT, C3AR1 | CFB 690/4885OPRL1 1475/4885OPRM1 1137/4885 |
| US-20140319331-A1 | NEW USE FOR A COMPOUND AS A MATRIX IN THE SPECIFIC DETECTION, IDENTIFICATION AND/OR QUANTIFICATION OF ALKALOIDS BY MALDI-TOF MASS SPECTROMETRY | CIAPIN1, SRMS, MMP7 | CFB 580/4885OPRL1 3543/4885OPRM1 2332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.